Asthma Clinical Trial
Official title:
Importance of Non-Acid Reflux in Moderate and Severe Asthma
The purpose of the study is to follow the medical course of children with moderate to severe asthma and see how this relates to whether they have acid of non-acid gastroesophageal reflux
Research Plan
Hypothesis and Specific Aims:
Asthma and gastroesophageal reflux are both common medical conditions in infants and
children as in adults, and often co-exist (Gibson 2002, Andze, 1991). Though an association
with overt reflux disease and asthma is well described and accepted, occult acid reflux has
also been shown to be associated with asthma. The vexing question has been whether
non-acidic reflux exacerbates asthma, particularly moderate to severe asthma. Current
approaches and the extensive literature to date have dealt with the role of acid reflux
only, and hence medical management is dominated by gastric acid suppression strategies
recently outlined by a consensus statement from the North American Society of Pediatric
Gastroenterology, Hepatology and Nutrition (Rudolph 2001). Based on this consensus, and
randomized double blind studies in adults, our strategy is to now use long-term proton pump
inhibitors. Clinically, this intervention has limited impact, and treatment failures are
common. Now that non-acid gastroesophageal reflux can be measured with the combined
impedance and pH probe, the role of non acid reflux can finally be evaluated. Our experience
thus far confirms findings of limited published pediatric studies using a significant role
for non-acid reflux in these "non -responders", and indeed suggests a greater role of
non-acid GER in extra-esophageal disorders in general. This new tool supercedes the standard
pH probe. Currently the standard of care for moderate to severe asthma is evaluation for
association with gastroesophageal reflux. These cases at NCC-Wilmington undergo 24 hour
combined impedance and pH study. With the advent of this new tool at NCC-Orlando also, we
plan to combine resources at several sites to accumulate data on prevalence of acid and
non-acid reflux in asthma. This would be an effective use of data retrieval attributes of
EPIC. Future studies looking at the impact of type of refluxate on bronchospasm, parenchymal
damage, and even chronic pulmonary vascularity changes prospectively would then be set up.
Since currently we have no specific recommendations for medical treatment of non-acid GER,
therapeutic strategies, either with existing or newer motility agents, could also be
evaluated in the future to develop practice guidelines.
Specific Aim:. What is the prevalence of acid and non-acid GER in moderate to severe asthma
patients referred for GI evaluation
Prevalence of acid and non-acid gastroesophageal reflux in children 1 to 18 yrs with
moderate asthma and severe asthma, referred for evaluation of gastroesophageal reflux at
NCC-Wilmington, New Jersey, and NCC-Orlando will be obtained. This information will be
extracted from EPIC templates that have current standards of care incorporated.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|